MedPath

Glucagon

Generic Name
Glucagon
Brand Names
Baqsimi, Glucagen, Gvoke, Ogluo
Drug Type
Biotech
CAS Number
16941-32-5
Unique Ingredient Identifier
76LA80IG2G

Overview

Glucagon is a 29 amino acid hormone used as a diagnostic aid in radiologic exams to temporarily inhibit the movement of the gastrointestinal tract and to treat severe hypoglycemia. Glucagon raises blood sugar through activation of hepatic glucagon receptors, stimulating glycogenolysis and the release of glucose. Glucagon was granted FDA approval on 14 November 1960.

Background

Glucagon is a 29 amino acid hormone used as a diagnostic aid in radiologic exams to temporarily inhibit the movement of the gastrointestinal tract and to treat severe hypoglycemia. Glucagon raises blood sugar through activation of hepatic glucagon receptors, stimulating glycogenolysis and the release of glucose. Glucagon was granted FDA approval on 14 November 1960.

Indication

Glucagon is indicated as a diagnostic aid in radiologic exams to temporarily inhibit the movement of the gastrointestinal tract and to treat severe hypoglycemia.

Associated Conditions

  • Severe Hypoglycemia

FDA Approved Products

Gvoke Kit
Manufacturer:Xeris Pharmaceuticals, Inc.
Route:SUBCUTANEOUS
Strength:1 mg in 0.2 mL
Approved: 2023/09/26
NDC:72065-140
Gvoke PFS 0.5 mg Pre-filled Syringe
Manufacturer:Xeris Pharmaceuticals, Inc.
Route:SUBCUTANEOUS
Strength:0.5 mg in 0.1 mL
Approved: 2023/09/26
NDC:72065-130
Gvoke PFS 1 mg Pre-filled Syringe
Manufacturer:Xeris Pharmaceuticals, Inc.
Route:SUBCUTANEOUS
Strength:1 mg in 0.2 mL
Approved: 2023/09/26
NDC:72065-131
Gvoke Kit Vial
Manufacturer:Xeris Pharmaceuticals, Inc.
Route:SUBCUTANEOUS
Strength:1 mg in 0.2 mL
Approved: 2023/09/26
NDC:72065-141
Gvoke HypoPen 1 mg Auto-Injector
Manufacturer:Xeris Pharmaceuticals, Inc.
Route:SUBCUTANEOUS
Strength:1 mg in 0.2 mL
Approved: 2023/09/26
NDC:72065-121

Singapore Approved Products

GLUCAGEN FOR INJECTION 1 mg/ml
Manufacturer:Novo Nordisk A/S, Novo Nordisk A/ S
Form:INJECTION, POWDER, FOR SOLUTION
Strength:1mg/ml
Online:Yes
Approved: 1996/12/09
Approval:SIN09070P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath